📰 Rob Volansky News
Page 2 - Rob Volansky News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rob Volansky. Real-time updates on events, politics, business and more.
April 13, 2022
Patients with hand synovial abnormalities in osteoarthritis demonstrate an abundance of two specific species of gut microbiota, according to findings presented at the 2022 OARSI World Congress.
April 13, 2022
A meta-analysis comparing exercise, opioids and NSAIDs yielded “disappointing” and inconsistent results, in which exercise generally demonstrated some benefit over opioids and NSAIDs, according to a speaker at the 2022 OARSI World Congress.
April 11, 2022
Understanding the “disturbance and breakdown” of cartilage is critical to finding and using biomarkers in osteoarthritis, according to the keynote speaker at the 2022 OARSI World Congress.
May 27, 2021
Given the limited awareness of non-radiographic axial spondyloarthritis, differentiating this disease from radiographic disease and prescribing appropriate therapy remains a key challenge, according to a presentation at the Biologic Therapies Summit. “Epidemiological knowledge in the United States about this disease is limited,” Marina Magrey, MD, the rheumatology fellowship program
May 26, 2021
While COVID-19 launched cytokine storm syndrome to the forefront of medical research, there is still much to be learned about these hyperactive immune events, according to a presenter at the Biologic Therapies Summit.“A cytokine storm is an immune dysregulation that causes collateral damage,” David Fajgenbaum, MD, MBA, MSc, assistant professor at the Perelman School of Medicine at the
May 23, 2021
Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio VEXAS syndrome is a recently discovered disease that features fever, orchitis, skin nodules and small- or medium-vessel vasculitis, among other symptoms, according to a presenter at the Biologic Therapies Summit. Peter Grayson, MD , head of the vasculitis translational research program and associate director of the NIAMS Fe...
May 21, 2021
Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis Source: Warrington K. When should biologic agents be introduced in giant cell arteritis and for how long should they be given? Presented at: Biologic Therapies Summit IX; May 21-23, 2021 (virtual meeting). Disclosures: Warrington reported no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email addre...
May 10, 2021
OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting Source: Quicke. The OARSI "Joint Effort Initiative" Repository of Online Osteoarthritis Management Programmes: An Implementation Rapid Response During COVID-19. Presented at: OARSI 2021 World Congress on Osteoarthritis; April 29-May 1. (virtual meeting). Disclosures: Quicke reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles...
February 19, 2021
Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio It is only natural that individuals taking immunosuppressive medications would fear COVID-19. However, recent findings add to a growing body of data indicating that immunosuppression may not elevate risk for worse outcomes for COVID-19 hospitalization. “This is a small amount of good news at a time in this pandemic...